Thursday, May 11, 2023 Daily Archives

Yposkesi launches LentiSure™, LV vector production platform optimized for higher yields

by

New lentiviral (LV) platform provides CAR-T developers with more robust capacity to drive clinical development and commercial cell and gene therapy pipelines. Evry-Courcouronnes (near Paris), France, April 2023 – Yposkesi, SK pharmteco’s clinical and commercial viral vector manufacturing arm for cell and gene therapies, today announces the launch of LentiSure™, an optimized Lentiviral (LV) Vector manufacturing platform for increasing lentivirus production efficiency and robustness. Lentivirus or LV vectors are used to produce cell-based immuno-oncology therapies. Their robustness as a gene…

May 11, 2023

Bioprocess transformation: It’s not just about the tech, says expert

by

To implement transformation successfully in your company, you must start with the person and not with the technology, an expert from GSK says. As the pharma space evolves rapidly, new modalities come online and the industry collectively pushes for faster times to market with lower costs. It is unsurprising that biotechs must semi-regularly implement and adapt new technologies. Speaking at BPI Europe 2023, Amsterdam, Fausto Artico, global R&D tech head of innovation and data science at GlaxoSmithKline (GSK), told delegates…

May 11, 2023